|
1
|
Ghosh P: Process of protein transport by
the type III secretion system. Microbiol Mol Biol Rev. 68:771–795.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braun M, Stuber K, Schlatter Y, Wahli T,
Kuhnert P and Frey J: Characterization of an ADP-ribosyltransferase
toxin (AexT) from Aeromonas salmonicida subsp
salmonicida. J Bacteriol. 184:1851–1858. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sha J, Wang SF, Suarez G, et al: Further
characterization of a type III secretion system (T3SS) and of a new
effector protein from a clinical isolate of Aeromonas
hydrophila - part I. Microb Pathog. 43:127–146. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sierra JC, Suarez G, Sha J, et al:
Biological characterization of a new type III secretion system
effector from a clinical isolate of Aeromonas
hydrophila-part II. Microb Pathog. 43:147–160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khajanchi BK, Sha J, Kozlova EV, et al:
N-acylhomoserine lactones involved in quorum sensing control the
type VI secretion system, biofilm formation, protease production,
and in vivo virulence in a clinical isolate of Aeromonas
hydrophila. Microbiology. 155:3518–3531. 2009. View Article : Google Scholar
|
|
6
|
LaFlamme SE, Nieves B, Colello D and
Reverte CG: Integrins as regulators of the mitotic machinery. Curr
Opin Cell Biol. 20:576–582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gilcrease MZ: Integrin signaling in
epithelial cells. Cancer Lett. 247:1–25. 2007. View Article : Google Scholar
|
|
8
|
Guo W and Giancotti FG: Integrin
signalling during tumour progression. Nat Rev Mol Cell Biol.
5:816–826. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vicente-Manzanares M, Choi CK and Horwitz
AR: Integrins in cell migration - the actin connection. J Cell Sci.
122:199–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abolghait SK, Iida T, Kodama T, Cantarelli
VV, Akeda Y and Honda T: Recombinant AexU effector protein of
Aeromonas veronii bv. sobria disrupts the actin cytoskeleton
by downregulation of Rac1 and induces direct cytotoxicity to
β4-integrin expressing cell lines. Microb Pathog. 51:454–465.
2011.PubMed/NCBI
|
|
11
|
Choi YP, Kim BG, Gao MQ, Kang S and Cho
NH: Targeting ILK and β4 integrin abrogates the invasive potential
of ovarian cancer. Biochem Biophys Res Commun. 427:642–648.
2012.
|
|
12
|
Gerson KD, Shearstone JR, Maddula VS,
Seligmann BE and Mercurio AM: Integrin β4 regulates SPARC protein
to promote invasion. J Biol Chem. 287:9835–9844. 2012.
|
|
13
|
Drake JM, Barnes JM, Madsen JM, Domann FE,
Stipp CS and Henry MD: ZEB1 coordinately regulates laminin-332 and
β4 integrin expression altering the invasive phenotype of prostate
cancer cells. J Biol Chem. 285:33940–33948. 2010.PubMed/NCBI
|
|
14
|
Bonaccorsi L, Carloni V, Muratori M, et
al: Androgen receptor expression in prostate carcinoma cells
suppresses alpha6beta4 integrin-mediated invasive phenotype.
Endocrinology. 141:3172–3182. 2000.
|
|
15
|
Davis TL, Cress AE, Dalkin BL and Nagle
RB: Unique expression pattern of the alpha6beta4 integrin and
laminin-5 in human prostate carcinoma. Prostate. 46:240–248. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Terakawa T, Miyake H, Furukawa J, Ettinger
SL, Gleave ME and Fujisawa M: Enhanced sensitivity to androgen
withdrawal due to overexpression of interleukin-6 in
androgen-dependent human prostate cancer LNCaP cells. Br J Cancer.
101:1731–1739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kususda Y, Miyake H, Gleave ME and
Fujisawa M: Clusterin inhibition using OGX-011 synergistically
enhances antitumour activity of sorafenib in a human renal cell
carcinoma model. Br J Cancer. 106:1945–1952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
|
|
19
|
Bluemn EG and Nelson PS: The
androgen/androgen receptor axis in prostate cancer. Curr Opin
Oncol. 24:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haddad H and Garcia JA: Novel agents for
the management of castration-resistant prostate cancer. Curr Opin
Urol. 22:175–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kurita A, Gotoh H, Eguchi M, et al:
Intracellular expression of the Salmonella plasmid virulence
protein, SpvB, causes apoptotic cell death in eukaryotic cells.
Microb Pathog. 35:43–48. 2003.
|
|
22
|
Bhattacharjee RN, Park KS, Kumagai Y, et
al: VP1686, a Vibrio type III secretion protein, induces toll-like
receptor-independent apoptosis in macrophage through NF-kappaB
inhibition. J Biol Chem. 281:36897–36904. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Molero C, Rodríguez-Escudero I, Alemán A,
Rotger R, Molina M and Cid VJ: Addressing the effects of
Salmonella internalization in host cell signaling on a
reverse-phase protein array. Proteomics. 9:3652–3665. 2009.
|
